Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.
Saved in:
| Title: | Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview. |
|---|---|
| Authors: | Dimou, Maria1 (AUTHOR) msdimou@med.uoa.gr, Fioretzaki, Rodanthi1 (AUTHOR), Zerzi, Calliope1 (AUTHOR), Konstantinou, Eliana1 (AUTHOR), Asimakopoulos, John V.1 (AUTHOR), Arapaki, Maria1 (AUTHOR), Piperidou, Alexia1 (AUTHOR), Machairas, Alexandros1 (AUTHOR), Kopsaftopoulou, Anastasia1 (AUTHOR), Liaskas, Athanasios1 (AUTHOR), Bitsani, Aikaterini1 (AUTHOR), Belia, Marina1 (AUTHOR), Panitsas, Fotios1 (AUTHOR), Benekou, Aikaterini1 (AUTHOR), Petsa, Panagiota1 (AUTHOR), Plata, Eleni1 (AUTHOR), Tsaftaridis, Panagiotis1 (AUTHOR), Siakantaris, Marina1 (AUTHOR), Vassilakopoulos, Theodoros P.1 (AUTHOR), Panayiotidis, Panayiotis1 (AUTHOR) |
| Source: | Cancers. Oct2025, Vol. 17 Issue 19, p3159. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
